Literature DB >> 26261532

MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.

Chao Ma1, Tao Huang1, Yue-Chao Ding1, Wei Yu1, Qian Wang1, Bo Meng1, Su-Xia Luo2.   

Abstract

INTRODUCTION: Cancer stem cells (CSCs) are believed to be 'seed cell' in cancer recurrence and metastasis. MicroRNAs (miRNAs) have emerged as potential therapeutic candidates due to their ability to regulate multiple targets involved in tumor progression and chemoresistance. The goal of this study was to investigate the role of miRNA-200c (miR-200c) in regulating colony formation, invasion and chemoresistance of human pancreatic cancer stem cells (PCSCs).
METHODS: PCSCs with CD24(+)CD44(+)ESA(+) as the marker was sorted from PANC-1 cell line by fluorescence activated cell sorter (FACS). Quantitative real-time PCR (qRT-PCR) assay was used to detect the expression of miR-200c in PCSCs and PANC-1 cells. Transfection of miR-200c mimic into PCSCs was performed to establish miR-200c over-expressed cells. The effects of overexpressing miR-200c on PCSCs were examined by cell colony forming, invasion and survival assays in vitro.
RESULTS: Our data showed that CD24(+)CD44(+)ESA(+) PCSCs (0.5%) were isolated from PANC-1 cells. Expression of miR-200c was significantly reduced in PCSCs compared with PANC-1 cells. In addition, the capability of colony formation, invasion and chemoresistance were markedly increased in PCSCs than that in PANC-1 cells. Adverse results were obtained in miR-200c overexpressing PCSCs transfected with miR-200c mimic.
CONCLUSION: Our study demonstrated that miR-200c overexpression could decrease colony formation, invasion and chemoresistance of PCSCs. It may become a new therapeutic target for gene therapy in patients suffered from pancreatic cancer.

Entities:  

Keywords:  Pancreatic cancer; cancer stem cells; chemoresistance; invasion; microRNA-200c

Mesh:

Substances:

Year:  2015        PMID: 26261532      PMCID: PMC4525866     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  16 in total

1.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 2.  Current status of surgery for pancreatic cancer.

Authors:  Koichi Hirata; Shinichi Egawa; Yasutoshi Kimura; Takayuki Nobuoka; Hidenori Oshima; Tadashi Katsuramaki; Toru Mizuguchi; Tomohisa Furuhata
Journal:  Dig Surg       Date:  2007-04-27       Impact factor: 2.588

Review 3.  The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis.

Authors:  Manav Korpal; Yibin Kang
Journal:  RNA Biol       Date:  2008 Jul-Sep       Impact factor: 4.652

Review 4.  Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.

Authors:  Sonja Gillen; Tibor Schuster; Christian Meyer Zum Büschenfelde; Helmut Friess; Jörg Kleeff
Journal:  PLoS Med       Date:  2010-04-20       Impact factor: 11.069

5.  Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin.

Authors:  Gregory J Hurteau; J Andrew Carlson; Simon D Spivack; Graham J Brock
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

6.  Report of incidence and mortality in China cancer registries, 2009.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Guanglin Li; Lingyou Wu; Jie He
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

7.  Characterization of clonogenic multiple myeloma cells.

Authors:  William Matsui; Carol Ann Huff; Qiuju Wang; Matthew T Malehorn; James Barber; Yvette Tanhehco; B Douglas Smith; Curt I Civin; Richard J Jones
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

8.  Identification of tumor stem-like cells in a mouse myeloma cell line.

Authors:  J Dou; Y Li; F Zhao; W Hu; P Wen; Q Tang; L Chu; Y Wang; M Cao; C Jiang; N Gu
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2009-08-05       Impact factor: 1.770

Review 9.  miRNA dysregulation in cancer: towards a mechanistic understanding.

Authors:  Jayanth Kumar Palanichamy; Dinesh S Rao
Journal:  Front Genet       Date:  2014-03-18       Impact factor: 4.599

Review 10.  MicroRNAs: regulators of oncogenesis and stemness.

Authors:  Thales Papagiannakopoulos; Kenneth S Kosik
Journal:  BMC Med       Date:  2008-06-24       Impact factor: 8.775

View more
  32 in total

Review 1.  Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.

Authors:  V Taucher; H Mangge; J Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2016-04-08       Impact factor: 6.730

Review 2.  microRNA regulation of human pancreatic cancer stem cells.

Authors:  Yi-Fan Xu; Bethany N Hannafon; Wei-Qun Ding
Journal:  Stem Cell Investig       Date:  2017-01-21

3.  G-Quadruplexes influence pri-microRNA processing.

Authors:  Samuel G Rouleau; Jean-Michel Garant; François Bolduc; Martin Bisaillon; Jean-Pierre Perreault
Journal:  RNA Biol       Date:  2017-12-11       Impact factor: 4.652

4.  Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.

Authors:  Amit Kumar Chaudhary; Goutam Mondal; Virender Kumar; Krishna Kattel; Ram I Mahato
Journal:  Cancer Lett       Date:  2017-05-20       Impact factor: 8.679

Review 5.  miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma.

Authors:  Anteneh A Tesfaye; Asfar S Azmi; Philip A Philip
Journal:  Am J Pathol       Date:  2019-01       Impact factor: 4.307

6.  A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients.

Authors:  Akhil Srivastava; Katherine Moxley; Rachel Ruskin; Danny Natarajan Dhanasekaran; Yan Daniel Zhao; Rajagopal Ramesh
Journal:  AAPS J       Date:  2018-07-09       Impact factor: 4.009

7.  A miRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition.

Authors:  Yi-Fan Zhao; Mei-Ling Han; Ya-Jie Xiong; Long Wang; Yao Fei; Xiao Shen; Ying Zhu; Zhong-Qin Liang
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

8.  MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition.

Authors:  Conghui Zhu; Xi Deng; Jingbo Wu; Jianwen Zhang; Hongru Yang; Shaozhi Fu; Yan Zhang; Yunwei Han; Yuanmei Zou; Zhengtang Chen; Sheng Lin
Journal:  Tumour Biol       Date:  2016-03-07

Review 9.  miRNA-regulated cancer stem cells: understanding the property and the role of miRNA in carcinogenesis.

Authors:  Chiranjib Chakraborty; Kok-Yong Chin; Srijit Das
Journal:  Tumour Biol       Date:  2016-07-28

Review 10.  miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.

Authors:  Merve Mutlu; Umar Raza; Özge Saatci; Erol Eyüpoğlu; Emre Yurdusev; Özgür Şahin
Journal:  J Mol Med (Berl)       Date:  2016-04-20       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.